Wnt signaling and human diseases: what are the therapeutic implications? (Q36702732)

15 August 2017

1 reference

title

Wnt signaling and human diseases: what are the therapeutic implications? (English)

1 reference

15 August 2017

Jinyong Luo

1

1 reference

15 August 2017

Jin Chen

2

1 reference

15 August 2017

Zhong-Liang Deng

3

1 reference

15 August 2017

Xiaoji Luo

4

1 reference

15 August 2017

Wen-Xin Song

5

1 reference

15 August 2017

Katie A Sharff

6

1 reference

15 August 2017

Ni Tang

7

1 reference

15 August 2017

Rex C Haydon

8

1 reference

15 August 2017

Hue H Luu

9

1 reference

15 August 2017

Tong-Chuan He

10

1 reference

15 August 2017

language of work or name

1 reference

8 January 2007

1 reference

15 August 2017

Laboratory Investigation

1 reference

15 August 2017

87

1 reference

15 August 2017

2

1 reference

15 August 2017

97-103

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3700509

15 August 2017

0 references

cites work

Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Mechanisms of Wnt signaling in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Wnt/beta-catenin signaling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Wnt signalling in stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Wnt and calcium signaling: beta-catenin-independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Wnt/beta-catenin signaling pathway as a novel cancer drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

WNT and beta-catenin signalling: diseases and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Beta-catenin is dispensable for hematopoiesis and lymphopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Identification of the haematopoietic stem cell niche and control of the niche size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Socializing with the neighbors: stem cells and their niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

A Wnt canon orchestrating osteoblastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Regulation of osteoblastogenesis and bone mass by Wnt10b

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Wnt signaling and the activation of myogenesis in mammals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Inhibition of adipogenesis by Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Lessons from hereditary colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

beta-catenin signaling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

The oncogenic activation of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Homozygous WNT3 mutation causes tetra-amelia in a large consanguineous family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/beta-catenin synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Renal development: perspectives on a Wnt-dependent process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

The polycystic kidney disease-1 promoter is a target of the beta-catenin/T-cell factor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Frizzled 4 gene (FZD4) mutations in patients with familial exudative vitreoretinopathy with variable expressivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

High bone density due to a mutation in LDL-receptor-related protein 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

The role of Axin2 in calvarial morphogenesis and craniosynostosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

WNT10B mutations in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Increased expression of Wnt-1 in schizophrenic brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

The human frizzled-3 (FZD3) gene on chromosome 8p21, a receptor gene for Wnt ligands, is associated with the susceptibility to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

GSK-3 and the neurodevelopmental hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Alzheimer's disease-do tauists and baptists finally shake hands?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Frizzled6 controls hair patterning in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Beta-catenin expression in Dupuytren's disease: potential role for cell-matrix interactions in modulating beta-catenin levels in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Sizing up the heart: development redux in disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

The wnt-frizzled cascade in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

A protein knockdown strategy to study the function of beta-catenin in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Eradication of pathogenic β-catenin by Skp1/Cullin/F box ubiquitination machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Targeted degradation of beta-catenin by chimeric F-box fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

beta-catenin: molecular plasticity and drug design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the β-catenin signaling activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

inferred from DOI database lookup

7 January 2021

based on heuristic

Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

inferred from DOI database lookup

7 January 2021

based on heuristic

Combinatorial chemoprevention of intestinal neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700509

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.3700509

1 reference

15 August 2017

1 reference